[Normophasic treatment].
Durandeau
D
D
D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D008234:Lynestrenol; D008599:Menstruation Disturbances; D008656:Mestranol; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D008234:Lynestrenol
Clinical Research; Contraception; Contraceptive Agents, Estrogen--therapeutic use; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Contraceptive Effectiveness; Diseases; Evaluation; Family Planning; Lynestrenol--therapeutic use; Menstruation Disorders; Mestranol--therapeutic use; Oral Contraceptives; Oral Contraceptives, Phasic; Research Methodology; Use-effectiveness